Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Acta Haematologica|January 31, 2022
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 PatientsDmitri Guz, Anat Gafter-Gvili, Nirit Lev, et al.Internal and Emergency Medicine|July 20, 2023
Ceftriaxone 1 g versus 2 g per day, for the treatment of community-acquired pneumonia: a retrospective cohort studyDmitri Guz, Rotem McNeil, Shira Buchrits, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 7, 2022
Ceftriaxone versus ampicillin for the treatment of community-acquired pneumonia. A propensity matched cohort studyDmitri Guz, Maayan Bracha, Yotam Steinberg, et al.The American Journal of Medicine|March 18, 2024
The Contribution of 18F FDG PET-CT for the Investigation of Fever of Unknown Origin and Inflammation of Unknown OriginShira Buchrits, Rotem McNeil, Tomer Avni, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
β-Blockers, Tachycardia, and Survival Following Sepsis: An Observational Cohort StudyDmitri Guz, Shira Buchritz, Alina Guz, et al.Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2022
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort studyKim Ben Tikva Kagan, Dmitri Guz, Shira Buchrits, et al.Cardiology|June 9, 2026
The Safety Profile of Ticagrelor Among Older Adults (age ≥ 75 years): A Pharmacovigilance AnalysisInbar Yacoby-Halevi, Boris Kruchin, Chen Gadot, et al.Journal of the American College of Cardiology|April 18, 2020
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1Andrea Mazzanti, Dmitri Guz, Alessandro Trancuccio, et al.Pageof 1